Since mutated KIT receptor is known to drive GIST sarcomas, it seemed possible that the moderate amplification of KITLG and resulting overexpression of the c-KIT ligand could be a driver, providing an autocrine loop. This evidence concerns the gene KITLG and sarcoma.